Benoit Immordino
Pisa, 56127, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resistance.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 11, 2025
Novel PPT+SEC Workflow for High-Sensitivity Extracellular Vesicle Proteomics from Cell Media.
Journal: Journal of proteome research
Published: May 02, 2025
Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems.
Journal: Seminars in cancer biology
Published: July 19, 2024
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 27, 2024
Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models.
Journal: International journal of pharmaceutics
Published: January 12, 2024
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism.
Journal: Cytokine & growth factor reviews
Published: August 11, 2023
"Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer.
Journal: Critical reviews in oncology/hematology
Published: March 07, 2022
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: December 27, 2021
CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage.
Journal: Molecules (Basel, Switzerland)
Published: November 12, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026